This topic contains a solution. Click here to go to the answer

Author Question: A patient who is receiving cancer chemotherapy has been ordered to receive epoetin alfa (Procrit) ... (Read 95 times)

leilurhhh

  • Hero Member
  • *****
  • Posts: 560
A patient who is receiving cancer chemotherapy has been ordered to receive epoetin alfa (Procrit) 150 units/kg 3 times weekly. The nurse reviews the patient's chart and notes a hemoglobin level of 10.1 g/dL.
 
  The nurse will perform which action?
  a. Administer the medication as ordered.
  b. Hold the dose and notify the provider.
  c. Reduce the dose by 25.
  d. Request an order for an increased dose.

Question 2

Prior to administration of interferon alpha, the nurse will administer which medications?
 
  a. Acetaminophen and diphenhydramine
  b. Heparin and meperidine
  c. Lorazepam and furosemide
  d. Narcotic analgesics and loratadine



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Swizqar

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

ANS: B
For patients receiving cancer chemotherapy, erythropoietin-stimulating agents should not be initiated at a hemoglobin level greater than or equal to 10 g/dL.

Answer to Question 2

ANS: A
Patients receiving these drugs should be premedicated with acetaminophen to reduce chills and fever and with diphenhydramine to reduce nausea.





 

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library